MedPath

H2O/O2-PET for determination of tumor hypoxia before and during radiotherapy in patients with head and neck cancer

Not Applicable
Recruiting
Conditions
C00-C14
Malignant neoplasms of lip, oral cavity and pharynx
Registration Number
DRKS00006058
Lead Sponsor
niversitätsSpital Zürich
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

Age = 18 years
- Signed Informed Consent
- 10 patients with histologically proven squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx
- Tumors large enough for PET imaging according to the judgement of the treating physicians
- Radio(chemo)therapy or radiotherapy in combination with cetuximab with curative intent

Exclusion Criteria

- Induction chemotherapy - Pregnant and lactating women

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasibility of H2O/O2 PET to determine changes in oxygen consumption and tumor hypoxia.
Secondary Outcome Measures
NameTimeMethod
Applicability of H2O/O2-PET/CT and biomarker analysis for hypoxia-adapted treatment planning, therapy monitoring and prognosis
© Copyright 2025. All Rights Reserved by MedPath